Foreign investors divested ₹4,521 crore from IT and ₹4,036 crore from healthcare stocks in the latter half of September. This selling was driven by concerns over US H-1B visa restrictions and new pharma tariffs, impacting export-oriented sectors. Overall, FPIs sold ₹19,647 crore across 15 sectors (...)
Site référencé: The Economic Times
The Economic Times
Aswath Damodaran flags a "fairly highly valued" market, lays out 5 ways investors can respond
7/10/2025
Morgan Stanley stake and a 75% upside call : Why this newly listed stock is drawing attention
7/10/2025
Dabur India Q2 Update : GST reforms, portfolio resilience drive momentum
7/10/2025
10 IPOs listing on exchanges tomorrow could offer up to 27% returns
7/10/2025
15 stocks to shop for this Diwali ; SBI Securities eyes up to 25% upside. Check list
7/10/2025
Pankaj Pandey bullish on Arvind Fashions and Trent as GST cuts boost margins
7/10/2025
